Terns Pharmaceuticals Inc (TERN) — Financial Flexibility Index
Terns Pharmaceuticals Inc (TERN) has a Financial Flexibility Index of -1.12x as of September 2025. Free cash flow of $-19.77 Million (operating CF $-19.77 Million minus capex $0.00) represents -1% of total liabilities ($17.59 Million). Also explore Terns Pharmaceuticals Inc net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Terns Pharmaceuticals Inc Financial Flexibility Index (2018–2024)
Historical Financial Flexibility Index trend for Terns Pharmaceuticals Inc across 7 annual periods. Check TERN strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Terns Pharmaceuticals Inc (2018–2024)
Year-by-year free cash flow to debt coverage for Terns Pharmaceuticals Inc. For the full company profile including market capitalisation, see how much is Terns Pharmaceuticals Inc worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -3.87x | $-69.97 Million | $-70.02 Million | $18.06 Million | ▲ +24.3% |
| 2023 | -5.12x | $-67.34 Million | $-67.39 Million | $13.15 Million | ▼ -5.7% |
| 2022 | -4.84x | $-48.83 Million | $-49.11 Million | $10.08 Million | ▲ +9.3% |
| 2021 | -5.34x | $-41.49 Million | $-41.83 Million | $7.77 Million | ▼ -333.1% |
| 2020 | -1.23x | $-29.23 Million | $-29.81 Million | $23.70 Million | ▲ +89.5% |
| 2019 | -11.71x | $-65.32 Million | $-66.22 Million | $5.58 Million | ▼ -1006.0% |
| 2018 | -1.06x | $-17.83 Million | $-18.07 Million | $16.84 Million | — |